ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 10 of 83 for:    Recruiting, Not yet recruiting, Available Studies | "Scleroderma, Systemic"

Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment (PRESSY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03262922
Recruitment Status : Recruiting
First Posted : August 25, 2017
Last Update Posted : August 25, 2017
Sponsor:
Information provided by (Responsible Party):
Rennes University Hospital

Brief Summary:
The aim of the study is to compare the exposure to environmental and professional toxics by patients with systemic scleroderma and by patients not achieved by this pathology.

Condition or disease
Systemic Scleroderma

Detailed Description:

This study is based on a questionnaire.

The data will be collected according a retrospective and prospective design :

  • at diagnostic of the disease
  • at the inclusion in the systemic scleroderma cohort
  • during the annual visit (in 2017-2018-2019-2020)

Study Type : Observational
Estimated Enrollment : 250 participants
Observational Model: Cohort
Time Perspective: Other
Official Title: Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment
Actual Study Start Date : July 29, 2016
Estimated Primary Completion Date : December 31, 2020
Estimated Study Completion Date : July 2021





Primary Outcome Measures :
  1. Questionnaire to evaluate the exposition of environmental and professional toxics [ Time Frame: once a year up to 2020 ]
    clinical, personal and professional data



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with systemic scleroderma
Criteria

Inclusion Criteria:

  • Patients with systemic scleroderma

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03262922


Contacts
Contact: Patrick JEGO, Pr PATRICK.JEGO@CHU-RENNES.FR
Contact: Alain LESCOAT

Locations
France
CHU de Rennes Recruiting
Rennes, France
Contact: Patrick JEGO, Pr       PATRICK.JEGO@CHU-RENNES.FR   
Sponsors and Collaborators
Rennes University Hospital
Investigators
Principal Investigator: Patrick JEGO, Pr Rennes University Hospital

Responsible Party: Rennes University Hospital
ClinicalTrials.gov Identifier: NCT03262922     History of Changes
Other Study ID Numbers: 35RC16_3032_PRESSY
First Posted: August 25, 2017    Key Record Dates
Last Update Posted: August 25, 2017
Last Verified: August 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Rennes University Hospital:
systemic scleroderma
environmental and professional toxics

Additional relevant MeSH terms:
Scleroderma, Systemic
Scleroderma, Diffuse
Scleroderma, Localized
Connective Tissue Diseases
Skin Diseases